Stay updated on Pembrolizumab for Refractory Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, as well as specific medical topics related to esophageal cancer and pembrolizumab. However, many related terms and previous location details have been removed.SummaryDifference2%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check22 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check29 days agoChange DetectedThe web page has been updated to version 2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference0.9%
- Check36 days agoChange DetectedThe web page has updated its version from v2.16.6 to v2.16.8 and added a section on HHS Vulnerability Disclosure.SummaryDifference0.2%
- Check43 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab for Refractory Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page.